Marco Rubio, Mike Waltz Introduce Bill to Reduce U.S. Dependency on China for Medical Supplies

Last week, U.S. Sen. Marco Rubio, R-Fla., brought out a bill to “combat America’s dependence on China for pharmaceuticals and to address associated supply chain risks that lead to shortages of critical drugs” that U.S. Rep. Mike Waltz, R-Fla., will champion in the U.S. House.

Rubio’s office insisted that the “Further Strengthening America’s Supply Chains and National Security Act” would follow up on a report he crafted in 2019. That year, Rubio unveiled “Made in China 2025 and the Future of American Industry” in which he “detailed critical vulnerabilities in America’s medical supply chain” and warned of America’s overreliance on China for pharmaceutical production.” Rubio’s office insisted that COVID pandemic only confirmed those warnings.